Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Rock

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2012
The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin CHajime Kono, Gregory M Orlowski, Zubin Patel, et al.
Advances in Immunology|June 25, 2002
Protein degradation and the generation of MHC class I-presented peptidesKenneth L Rock, Ian A York, Tomo Saric, et al.
Cancer|November 24, 2004
Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomasArmando Ciampa, Gary Fanger, Ashraf Khan, et al.
Plos One|August 16, 2014
Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responsesHiroshi Kataoka, Hajime Kono, Zubin Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivoMasahiro Kawahara, Ian A York, Arron Hearn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
A mutant cell with a novel defect in MHC class I quality controlIan A York, Ethan P Grant, A Maria Dahl, et al.
Cancer Immunology Research|November 1, 2024
Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of β2M or TAPFreidrich M Cruz, Laura A A Orellano, Amanda Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2022
Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activationJeff D Colbert, Freidrich M Cruz, Christina E Baer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentationIan A York, Nidhi Bhutani, Sophia Zendzian, et al.
Trends in Immunology|February 26, 2014
Re-examining class-I presentation and the DRiP hypothesisKenneth L Rock, Diego J Farfán-Arribas, Jeff D Colbert, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2012
The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin CHajime Kono, Gregory M Orlowski, Zubin Patel, et al.
Advances in Immunology|June 25, 2002
Protein degradation and the generation of MHC class I-presented peptidesKenneth L Rock, Ian A York, Tomo Saric, et al.
Cancer|November 24, 2004
Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomasArmando Ciampa, Gary Fanger, Ashraf Khan, et al.
Plos One|August 16, 2014
Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responsesHiroshi Kataoka, Hajime Kono, Zubin Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivoMasahiro Kawahara, Ian A York, Arron Hearn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
A mutant cell with a novel defect in MHC class I quality controlIan A York, Ethan P Grant, A Maria Dahl, et al.
Cancer Immunology Research|November 1, 2024
Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of β2M or TAPFreidrich M Cruz, Laura A A Orellano, Amanda Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2022
Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activationJeff D Colbert, Freidrich M Cruz, Christina E Baer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentationIan A York, Nidhi Bhutani, Sophia Zendzian, et al.
Trends in Immunology|February 26, 2014
Re-examining class-I presentation and the DRiP hypothesisKenneth L Rock, Diego J Farfán-Arribas, Jeff D Colbert, et al.
Pageof 9